
Dean Hart
CEO,
RS BioTherapeutics, Inc.
United States
40 years of extensive biopharmaceutical experience including roles of increasing responsibility at Bristol-Myers Squibb, Eisai, Takeda Pharmaceuticals North America, and Adamas Pharmaceuticals. Has built, launched and led organizations for two multi-billion-dollar brands.
Sessions
-
17-Oct-2023